Arin Ashkan
Foot & Ankle Surgery · Vienna, VANPI 1104208578
Payments from drug & device makers
Across 49 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medicomp Inc$123
- Paratek Pharmaceuticals, Inc.$109
- Organogenesis Inc.$90
- Convatec Inc.$74
- AbbVie$70
- Amgen$67
- plus $545 from 18 others
What the payments were for
- Food & beverage$1,077100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medicomp Inc | 5 | $123 |
| Paratek Pharmaceuticals, Inc. | 5 | $109 |
| Organogenesis Inc. | 3 | $90 |
| Convatec Inc. | 4 | $74 |
| AbbVie | 3 | $70 |
| Amgen(2 entities) | 3 | $67 |
| Johnson & Johnson | 3 | $58 |
| Reprise Biomedical, Inc. | 3 | $56 |
| Tactile Systems Technology Inc | 3 | $50 |
| Nevro Corp. | 2 | $48 |
| Triad Life Sciences Inc. | 2 | $41 |
| Hydrofera LLC | 1 | $38 |
| Aroa Biosurgery Incorporated | 1 | $32 |
| Medtronic | 1 | $30 |
| AstraZeneca | 1 | $24 |
| Merck | 1 | $23 |
| Atricure, Inc. | 1 | $22 |
| Bioventus LLC | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $21 |
| Kerecis Limited | 1 | $18 |
| Hartmann USA, Inc. | 1 | $18 |
| Molnlycke Health Care US, LLC | 1 | $18 |
| Zimmer Biomet | 1 | $16 |
| Advanced Oxygen Therapy Inc. | 1 | $12 |
How this compares
$1,077 in reported general payments places this provider in the 25th percentile of 260 foot & ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 91 | $1,729 |
| Diclofenac Sodium | 66 | $1,329 |
| Ciclopirox | 33 | $753 |
| Cephalexin | 64 | $734 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $550 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 46 | $293 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 15 | $292 |
| Ammonium Lactate | 17 | $196 |
| Terbinafine Hcl | 16 | $122 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $67 |
| Meloxicam | 33 | $40 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Vienna
- Shruti PatelVienna$47K
- Charles ZelenRoanoke$6.2M
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Steven NeufeldFalls Church$1.2M
- Matthew DairmanSuffolk$376K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
- William SimonVirginia Beach$292K
- Bradley LevittVirginia Beach$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.